AI-powered FDG-PET Radiomics: a Door to Better Alzheimer's Disease Classification?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C
. Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590.
PMC: 8354300.
DOI: 10.1016/S0140-6736(20)32205-4.
View
2.
Petersen R, Lopez O, Armstrong M, Getchius T, Ganguli M, Gloss D
. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017; 90(3):126-135.
PMC: 5772157.
DOI: 10.1212/WNL.0000000000004826.
View
3.
Gordon C, Martin D
. Mild cognitive impairment. Expert Rev Neurother. 2013; 13(11):1247-61.
DOI: 10.1586/14737175.2013.856265.
View
4.
Chandra A, Valkimadi P, Pagano G, Cousins O, Dervenoulas G, Politis M
. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment. Hum Brain Mapp. 2019; 40(18):5424-5442.
PMC: 6864887.
DOI: 10.1002/hbm.24782.
View
5.
Etminani K, Soliman A, Davidsson A, Chang J, Martinez-Sanchis B, Byttner S
. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2021; 49(2):563-584.
PMC: 8803724.
DOI: 10.1007/s00259-021-05483-0.
View